Drug Formulary Review Archives – November 1, 2006
November 1, 2006
View Archives Issues
-
ASHP urges hospitals to take steps to evaluate medication use systems
In the wake of a drug safety accident at Indianapolis' Methodist Hospital that killed two infants and left four others seriously ill, the American Society of Health-System Pharmacists (ASHP) called on hospitals to critically evaluate their medication use systems to help avoid dangerous or fatal errors. -
South Carolina hospital cuts 'rate of harm'
In the wake of the Institute of Medicine report on medication errors, Florence, South Carolina's McLeod Regional Medical Center initiated a series of steps to improve patient safety and reduce the hospital's "rate of harm." -
Society wants pharmacists to head pharmacy services
The Canadian Society of Hospital Pharmacists (CSHP) says only licensed pharmacists should be named to head hospital-based pharmacy services. "A licensed pharmacist can be held accountable for the quality of professional pharmacy services and operations," the society says in a position statement. -
Multidisciplinary approach may overcome ICU barriers
Published clinical trials have demonstrated morbidity and mortality benefits of moderate-to-tight glycemic control in critically ill patients. Despite a growing body of evidence supporting use of this beneficial intervention, attaining such glucose control remains difficult. -
Risks of accidental poisonings explored
With the U.S. Consumer Product Safety Commission warning that unintentional poisonings are responsible for more than 1 million calls to poison control centers and 78,000 hospital visits for children younger than age 5 in 2003, Southwestern Oklahoma State University professor of nonprescription products and devices W. Steven Pray, PhD, DPh, outlined in U.S. Pharmacist some recent developments in poison control. -
Drug Criteria & Outcomes: Breathe Your Way to Tighter Glycemic Control
Is inhaled insulin (Exubera®, insulin human [rDNA origin]) really as efficacious as regular humulin insulin subcutaneous (RHISQ)? Is it really just as simple as taking a breath or does complicated dosing create a barrier that makes it difficult for patients to self manage their disease? -
News Brief
Judge: IL pharmacists may challenge EC law -
New FDA Approvals
FDA recently approved this drug: Schering's Noxafil (posaconazole) was approved with an indication for preventing fungal infections caused by certain molds and yeast-like Aspergillus and Candida fungi. -
2006 Salary Survey Results: Surveyed pharmacists report earning more than $100,000 per year
Of 11 pharmacists who responded to the 2006 Drug Formulary Review salary survey, six are earning between $100,000 and $129,999 (see chart), while three earn $130,000 or more and the salary for the remaining two is less than $59,999.